Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Opioids Agonist Drugs Market 2018, Forecast to 2023

January 2019 | 136 pages | ID: GD605A2054BEN
GlobalInfoResearch

Abstracts

Opioid drugs act on the opioid receptors present in the central and peripheral nervous system. The drug class primarily used in relieving pain includes natural, semi-synthetic, and synthetic opioids.Opioids can be administered as oral pills, parenteral, liquids, patches, or lozenges.

Scope of the Report:

This report focuses on the Opioids Agonist Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Legalizing Cannabis to Impact Opioids Agonist Drugs Market Growth

The worldwide market for Opioids Agonist Drugs is expected to grow at a CAGR of roughly 4.2% over the next five years, will reach 23800 million US$ in 2023, from 18600 million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

• Purdue Pharma
• Titan pharmaceuticals
• Boehringer Ingelheim
• Janssen Pharmaceuticals, Inc
• Sanofi
• Sun Pharmaceuticals
• Mallinckrodt Pharmaceuticals
• Egalet Corporation
• Endo Pharmaceuticals Inc.
• Allergan, Plc
• Pfizer Inc

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia etc.)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Codeine
• Fentanyl
• Meperidine
• Methadone
• Morphine
• Hydrocodone

Market Segment by Applications, can be divided into

• Pain Management
• Cough Treatment
• Diarrhea Treatment

There are 15 Chapters to deeply display the global Opioids Agonist Drugs market.

Chapter 1, to describe Opioids Agonist Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Opioids Agonist Drugs, with sales, revenue, and price of Opioids Agonist Drugs, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Opioids Agonist Drugs, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Opioids Agonist Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Opioids Agonist Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Contents

1 MARKET OVERVIEW

1.1 Opioids Agonist Drugs Introduction
1.2 Market Analysis by Type
  1.2.1 Codeine
  1.2.2 Fentanyl
  1.2.3 Meperidine
  1.2.4 Methadone
  1.2.5 Morphine
  1.2.6 Hydrocodone
1.3 Market Analysis by Applications
  1.3.1 Pain Management
  1.3.2 Cough Treatment
  1.3.3 Diarrhea Treatment
1.4 Market Analysis by Regions
  1.4.1 North America (United States, Canada and Mexico)
    1.4.1.1 United States Market States and Outlook (2013-2023)
    1.4.1.2 Canada Market States and Outlook (2013-2023)
    1.4.1.3 Mexico Market States and Outlook (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy)
    1.4.2.1 Germany Market States and Outlook (2013-2023)
    1.4.2.2 France Market States and Outlook (2013-2023)
    1.4.2.3 UK Market States and Outlook (2013-2023)
    1.4.2.4 Russia Market States and Outlook (2013-2023)
    1.4.2.5 Italy Market States and Outlook (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
    1.4.3.1 China Market States and Outlook (2013-2023)
    1.4.3.2 Japan Market States and Outlook (2013-2023)
    1.4.3.3 Korea Market States and Outlook (2013-2023)
    1.4.3.4 India Market States and Outlook (2013-2023)
    1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
  1.4.4 South America, Middle East and Africa
    1.4.4.1 Brazil Market States and Outlook (2013-2023)
    1.4.4.2 Egypt Market States and Outlook (2013-2023)
    1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
    1.4.4.4 South Africa Market States and Outlook (2013-2023)
    1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
  1.5.1 Market Opportunities
  1.5.2 Market Risk
  1.5.3 Market Driving Force

2 MANUFACTURERS PROFILES

2.1 Purdue Pharma
  2.1.1 Business Overview
    2.1.1.1 Purdue Pharma Description
    2.1.1.2 Purdue Pharma Headquarter, Main Business and Finance Overview
  2.1.2 Purdue Pharma Opioids Agonist Drugs Product Introduction
    2.1.2.1 Opioids Agonist Drugs Production Bases, Sales Regions and Major Competitors
    2.1.2.2 Opioids Agonist Drugs Product Information
  2.1.3 Purdue Pharma Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.1.3.1 Purdue Pharma Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.1.3.2 Global Purdue Pharma Opioids Agonist Drugs Market Share in 2017
2.2 Titan pharmaceuticals
  2.2.1 Business Overview
    2.2.1.1 Titan pharmaceuticals Description
    2.2.1.2 Titan pharmaceuticals Headquarter, Main Business and Finance Overview
  2.2.2 Titan pharmaceuticals Opioids Agonist Drugs Product Introduction
    2.2.2.1 Opioids Agonist Drugs Production Bases, Sales Regions and Major Competitors
    2.2.2.2 Opioids Agonist Drugs Product Information
  2.2.3 Titan pharmaceuticals Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.2.3.1 Titan pharmaceuticals Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.2.3.2 Global Titan pharmaceuticals Opioids Agonist Drugs Market Share in 2017
2.3 Boehringer Ingelheim
  2.3.1 Business Overview
    2.3.1.1 Boehringer Ingelheim Description
    2.3.1.2 Boehringer Ingelheim Headquarter, Main Business and Finance Overview
  2.3.2 Boehringer Ingelheim Opioids Agonist Drugs Product Introduction
    2.3.2.1 Opioids Agonist Drugs Production Bases, Sales Regions and Major Competitors
    2.3.2.2 Opioids Agonist Drugs Product Information
  2.3.3 Boehringer Ingelheim Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.3.3.1 Boehringer Ingelheim Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.3.3.2 Global Boehringer Ingelheim Opioids Agonist Drugs Market Share in 2017
2.4 Janssen Pharmaceuticals, Inc
  2.4.1 Business Overview
    2.4.1.1 Janssen Pharmaceuticals, Inc Description
    2.4.1.2 Janssen Pharmaceuticals, Inc Headquarter, Main Business and Finance Overview
  2.4.2 Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Product Introduction
    2.4.2.1 Opioids Agonist Drugs Production Bases, Sales Regions and Major Competitors
    2.4.2.2 Opioids Agonist Drugs Product Information
  2.4.3 Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.4.3.1 Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.4.3.2 Global Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Market Share in 2017
2.5 Sanofi
  2.5.1 Business Overview
    2.5.1.1 Sanofi Description
    2.5.1.2 Sanofi Headquarter, Main Business and Finance Overview
  2.5.2 Sanofi Opioids Agonist Drugs Product Introduction
    2.5.2.1 Opioids Agonist Drugs Production Bases, Sales Regions and Major Competitors
    2.5.2.2 Opioids Agonist Drugs Product Information
  2.5.3 Sanofi Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.5.3.1 Sanofi Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.5.3.2 Global Sanofi Opioids Agonist Drugs Market Share in 2017
2.6 Sun Pharmaceuticals
  2.6.1 Business Overview
    2.6.1.1 Sun Pharmaceuticals Description
    2.6.1.2 Sun Pharmaceuticals Headquarter, Main Business and Finance Overview
  2.6.2 Sun Pharmaceuticals Opioids Agonist Drugs Product Introduction
    2.6.2.1 Opioids Agonist Drugs Production Bases, Sales Regions and Major Competitors
    2.6.2.2 Opioids Agonist Drugs Product Information
  2.6.3 Sun Pharmaceuticals Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.6.3.1 Sun Pharmaceuticals Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.6.3.2 Global Sun Pharmaceuticals Opioids Agonist Drugs Market Share in 2017
2.7 Mallinckrodt Pharmaceuticals
  2.7.1 Business Overview
    2.7.1.1 Mallinckrodt Pharmaceuticals Description
    2.7.1.2 Mallinckrodt Pharmaceuticals Headquarter, Main Business and Finance Overview
  2.7.2 Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Product Introduction
    2.7.2.1 Opioids Agonist Drugs Production Bases, Sales Regions and Major Competitors
    2.7.2.2 Opioids Agonist Drugs Product Information
  2.7.3 Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.7.3.1 Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.7.3.2 Global Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Market Share in 2017
2.8 Egalet Corporation
  2.8.1 Business Overview
    2.8.1.1 Egalet Corporation Description
    2.8.1.2 Egalet Corporation Headquarter, Main Business and Finance Overview
  2.8.2 Egalet Corporation Opioids Agonist Drugs Product Introduction
    2.8.2.1 Opioids Agonist Drugs Production Bases, Sales Regions and Major Competitors
    2.8.2.2 Opioids Agonist Drugs Product Information
  2.8.3 Egalet Corporation Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.8.3.1 Egalet Corporation Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.8.3.2 Global Egalet Corporation Opioids Agonist Drugs Market Share in 2017
2.9 Endo Pharmaceuticals Inc.
  2.9.1 Business Overview
    2.9.1.1 Endo Pharmaceuticals Inc. Description
    2.9.1.2 Endo Pharmaceuticals Inc. Headquarter, Main Business and Finance Overview
  2.9.2 Endo Pharmaceuticals Inc. Opioids Agonist Drugs Product Introduction
    2.9.2.1 Opioids Agonist Drugs Production Bases, Sales Regions and Major Competitors
    2.9.2.2 Opioids Agonist Drugs Product Information
  2.9.3 Endo Pharmaceuticals Inc. Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.9.3.1 Endo Pharmaceuticals Inc. Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.9.3.2 Global Endo Pharmaceuticals Inc. Opioids Agonist Drugs Market Share in 2017
2.10 Allergan, Plc
  2.10.1 Business Overview
    2.10.1.1 Allergan, Plc Description
    2.10.1.2 Allergan, Plc Headquarter, Main Business and Finance Overview
  2.10.2 Allergan, Plc Opioids Agonist Drugs Product Introduction
    2.10.2.1 Opioids Agonist Drugs Production Bases, Sales Regions and Major Competitors
    2.10.2.2 Opioids Agonist Drugs Product Information
  2.10.3 Allergan, Plc Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.10.3.1 Allergan, Plc Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.10.3.2 Global Allergan, Plc Opioids Agonist Drugs Market Share in 2017
2.11 Pfizer Inc
  2.11.1 Business Overview
  2.11.2 Pfizer Inc Opioids Agonist Drugs Product Introduction
  2.11.3 Pfizer Inc Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL OPIOIDS AGONIST DRUGS MARKET COMPETITION, BY MANUFACTURER

3.1 Global Opioids Agonist Drugs Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Opioids Agonist Drugs Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Opioids Agonist Drugs Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
  3.4.1 Top 3 Opioids Agonist Drugs Manufacturer Market Share in 2017
  3.4.2 Top 5 Opioids Agonist Drugs Manufacturer Market Share in 2017
3.5 Market Competition Trend

4 GLOBAL OPIOIDS AGONIST DRUGS MARKET ANALYSIS BY REGIONS

4.1 Global Opioids Agonist Drugs Sales, Revenue and Market Share by Regions
  4.1.1 Global Opioids Agonist Drugs Sales by Regions (2013-2018)
  4.1.2 Global Opioids Agonist Drugs Revenue by Regions (2013-2018)
4.2 North America Opioids Agonist Drugs Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Opioids Agonist Drugs Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Opioids Agonist Drugs Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Opioids Agonist Drugs Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Opioids Agonist Drugs Sales, Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA OPIOIDS AGONIST DRUGS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

5.1 North America Opioids Agonist Drugs Sales, Revenue and Market Share by Countries
  5.1.1 North America Opioids Agonist Drugs Sales by Countries (2013-2018)
  5.1.2 North America Opioids Agonist Drugs Revenue by Countries (2013-2018)
  5.1.3 United States Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
  5.1.4 Canada Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
  5.1.5 Mexico Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
5.2 North America Opioids Agonist Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)
  5.2.1 North America Opioids Agonist Drugs Sales by Manufacturers (2016-2017)
  5.2.2 North America Opioids Agonist Drugs Revenue by Manufacturers (2016-2017)
5.3 North America Opioids Agonist Drugs Sales, Revenue and Market Share by Type (2013-2018)
  5.3.1 North America Opioids Agonist Drugs Sales and Sales Share by Type (2013-2018)
  5.3.2 North America Opioids Agonist Drugs Revenue and Revenue Share by Type (2013-2018)
5.4 North America Opioids Agonist Drugs Sales, Revenue and Market Share by Application (2013-2018)
  5.4.1 North America Opioids Agonist Drugs Sales and Sales Share by Application (2013-2018)
  5.4.2 North America Opioids Agonist Drugs Revenue and Revenue Share by Application (2013-2018)

6 EUROPE OPIOIDS AGONIST DRUGS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

6.1 Europe Opioids Agonist Drugs Sales, Revenue and Market Share by Countries
  6.1.1 Europe Opioids Agonist Drugs Sales by Countries (2013-2018)
  6.1.2 Europe Opioids Agonist Drugs Revenue by Countries (2013-2018)
  6.1.3 Germany Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
  6.1.4 UK Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
  6.1.5 France Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
  6.1.6 Russia Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
  6.1.7 Italy Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
6.2 Europe Opioids Agonist Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)
  6.2.1 Europe Opioids Agonist Drugs Sales by Manufacturers (2016-2017)
  6.2.2 Europe Opioids Agonist Drugs Revenue by Manufacturers (2016-2017)
6.3 Europe Opioids Agonist Drugs Sales, Revenue and Market Share by Type (2013-2018)
  6.3.1 Europe Opioids Agonist Drugs Sales and Sales Share by Type (2013-2018)
  6.3.2 Europe Opioids Agonist Drugs Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Opioids Agonist Drugs Sales, Revenue and Market Share by Application (2013-2018)
  6.4.1 Europe Opioids Agonist Drugs Sales and Sales Share by Application (2013-2018)
  6.4.2 Europe Opioids Agonist Drugs Revenue and Revenue Share by Application (2013-2018)

7 ASIA-PACIFIC OPIOIDS AGONIST DRUGS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

7.1 Asia-Pacific Opioids Agonist Drugs Sales, Revenue and Market Share by Countries
  7.1.1 Asia-Pacific Opioids Agonist Drugs Sales by Countries (2013-2018)
  7.1.2 Asia-Pacific Opioids Agonist Drugs Revenue by Countries (2013-2018)
  7.1.3 China Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
  7.1.4 Japan Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
  7.1.5 Korea Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
  7.1.6 India Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
  7.1.7 Southeast Asia Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Opioids Agonist Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)
  7.2.1 Asia-Pacific Opioids Agonist Drugs Sales by Manufacturers (2016-2017)
  7.2.2 Asia-Pacific Opioids Agonist Drugs Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Opioids Agonist Drugs Sales, Revenue and Market Share by Type (2013-2018)
  7.3.1 Asia-Pacific Opioids Agonist Drugs Sales and Sales Share by Type (2013-2018)
  7.3.2 Asia-Pacific Opioids Agonist Drugs Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Opioids Agonist Drugs Sales, Revenue and Market Share by Application (2013-2018)
  7.4.1 Asia-Pacific Opioids Agonist Drugs Sales and Sales Share by Application (2013-2018)
  7.4.2 Asia-Pacific Opioids Agonist Drugs Revenue and Revenue Share by Application (2013-2018)

8 SOUTH AMERICA OPIOIDS AGONIST DRUGS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

8.1 South America Opioids Agonist Drugs Sales, Revenue and Market Share by Countries
  8.1.1 South America Opioids Agonist Drugs Sales by Countries (2013-2018)
  8.1.2 South America Opioids Agonist Drugs Revenue by Countries (2013-2018)
  8.1.3 Brazil Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
  8.1.4 Argentina Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
  8.1.5 Colombia Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
8.2 South America Opioids Agonist Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)
  8.2.1 South America Opioids Agonist Drugs Sales by Manufacturers (2016-2017)
  8.2.2 South America Opioids Agonist Drugs Revenue by Manufacturers (2016-2017)
8.3 South America Opioids Agonist Drugs Sales, Revenue and Market Share by Type (2013-2018)
  8.3.1 South America Opioids Agonist Drugs Sales and Sales Share by Type (2013-2018)
  8.3.2 South America Opioids Agonist Drugs Revenue and Revenue Share by Type (2013-2018)
8.4 South America Opioids Agonist Drugs Sales, Revenue and Market Share by Application (2013-2018)
  8.4.1 South America Opioids Agonist Drugs Sales and Sales Share by Application (2013-2018)
  8.4.2 South America Opioids Agonist Drugs Revenue and Revenue Share by Application (2013-2018)

9 MIDDLE EAST AND AFRICA OPIOIDS AGONIST DRUGS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

9.1 Middle East and Africa Opioids Agonist Drugs Sales, Revenue and Market Share by Countries
  9.1.1 Middle East and Africa Opioids Agonist Drugs Sales by Countries (2013-2018)
  9.1.2 Middle East and Africa Opioids Agonist Drugs Revenue by Countries (2013-2018)
  9.1.3 Saudi Arabia Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
  9.1.4 UAE Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
  9.1.5 Egypt Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
  9.1.6 Nigeria Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
  9.1.7 South Africa Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Opioids Agonist Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)
  9.2.1 Middle East and Africa Opioids Agonist Drugs Sales by Manufacturers (2016-2017)
  9.2.2 Middle East and Africa Opioids Agonist Drugs Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Opioids Agonist Drugs Sales, Revenue and Market Share by Type (2013-2018)
  9.3.1 Middle East and Africa Opioids Agonist Drugs Sales and Sales Share by Type (2013-2018)
  9.3.1 Middle East and Africa Opioids Agonist Drugs Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Opioids Agonist Drugs Sales, Revenue and Market Share by Application (2013-2018)
  9.4.1 Middle East and Africa Opioids Agonist Drugs Sales and Sales Share by Application (2013-2018)
  9.4.2 Middle East and Africa Opioids Agonist Drugs Revenue and Revenue Share by Application (2013-2018)

10 GLOBAL OPIOIDS AGONIST DRUGS MARKET SEGMENT BY TYPE

10.1 Global Opioids Agonist Drugs Sales, Revenue and Market Share by Type (2013-2018)
  10.1.1 Global Opioids Agonist Drugs Sales and Market Share by Type (2013-2018)
  10.1.2 Global Opioids Agonist Drugs Revenue and Market Share by Type (2013-2018)
10.2 Codeine Sales Growth and Price
  10.2.1 Global Codeine Sales Growth (2013-2018)
  10.2.2 Global Codeine Price (2013-2018)
10.3 Fentanyl Sales Growth and Price
  10.3.1 Global Fentanyl Sales Growth (2013-2018)
  10.3.2 Global Fentanyl Price (2013-2018)
10.4 Meperidine Sales Growth and Price
  10.4.1 Global Meperidine Sales Growth (2013-2018)
  10.4.2 Global Meperidine Price (2013-2018)
10.5 Methadone Sales Growth and Price
  10.5.1 Global Methadone Sales Growth (2013-2018)
  10.5.2 Global Methadone Price (2013-2018)
10.6 Morphine Sales Growth and Price
  10.6.1 Global Morphine Sales Growth (2013-2018)
  10.6.2 Global Morphine Price (2013-2018)
10.7 Hydrocodone Sales Growth and Price
  10.7.1 Global Hydrocodone Sales Growth (2013-2018)
  10.7.2 Global Hydrocodone Price (2013-2018)

11 GLOBAL OPIOIDS AGONIST DRUGS MARKET SEGMENT BY APPLICATION

11.1 Global Opioids Agonist Drugs Sales Market Share by Application (2013-2018)
11.2 Pain Management Sales Growth (2013-2018)
11.3 Cough Treatment Sales Growth (2013-2018)
11.4 Diarrhea Treatment Sales Growth (2013-2018)

12 OPIOIDS AGONIST DRUGS MARKET FORECAST (2018-2023)

12.1 Global Opioids Agonist Drugs Sales, Revenue and Growth Rate (2018-2023)
12.2 Opioids Agonist Drugs Market Forecast by Regions (2018-2023)
  12.2.1 North America Opioids Agonist Drugs Market Forecast (2018-2023)
  12.2.2 Europe Opioids Agonist Drugs Market Forecast (2018-2023)
  12.2.3 Asia-Pacific Opioids Agonist Drugs Market Forecast (2018-2023)
  12.2.4 South America Opioids Agonist Drugs Market Forecast (2018-2023)
  12.2.5 Middle East and Africa Opioids Agonist Drugs Market Forecast (2018-2023)
12.3 Opioids Agonist Drugs Market Forecast by Type (2018-2023)
  12.3.1 Global Opioids Agonist Drugs Sales Forecast by Type (2018-2023)
  12.3.2 Global Opioids Agonist Drugs Market Share Forecast by Type (2018-2023)
12.4 Opioids Agonist Drugs Market Forecast by Application (2018-2023)
  12.4.1 Global Opioids Agonist Drugs Sales Forecast by Application (2018-2023)
  12.4.2 Global Opioids Agonist Drugs Market Share Forecast by Application (2018-2023)

13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS

13.1 Sales Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers

14 RESEARCH FINDINGS AND CONCLUSION

15 APPENDIX

15.1 Methodology
15.2 Data

List Of Tables

LIST OF TABLES AND FIGURES

Figure Opioids Agonist Drugs Picture
Table Product Specifications of Opioids Agonist Drugs
Figure Global Opioids Agonist Drugs CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Global Opioids Agonist Drugs CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales)
Figure Global Sales Market Share of Opioids Agonist Drugs by Types in 2017
Figure Codeine Picture
Table Major Manufacturers of Codeine
Figure Fentanyl Picture
Table Major Manufacturers of Fentanyl
Figure Meperidine Picture
Table Major Manufacturers of Meperidine
Figure Methadone Picture
Table Major Manufacturers of Methadone
Figure Morphine Picture
Table Major Manufacturers of Morphine
Figure Hydrocodone Picture
Table Major Manufacturers of Hydrocodone
Figure Opioids Agonist Drugs Sales Market Share by Applications in 2017
Figure Pain Management Picture
Figure Cough Treatment Picture
Figure Diarrhea Treatment Picture
Figure United States Opioids Agonist Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Opioids Agonist Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Opioids Agonist Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Opioids Agonist Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure France Opioids Agonist Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure UK Opioids Agonist Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Opioids Agonist Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Opioids Agonist Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure China Opioids Agonist Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Opioids Agonist Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Opioids Agonist Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure India Opioids Agonist Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Opioids Agonist Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Opioids Agonist Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Opioids Agonist Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Opioids Agonist Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Opioids Agonist Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Opioids Agonist Drugs Revenue (Value) and Growth Rate (2013-2023)
Table Purdue Pharma Headquarter, Established, Main Business and Finance Overview (2017)
Table Purdue Pharma Opioids Agonist Drugs Production Bases, Sales Regions and Major Competitors
Table Purdue Pharma Opioids Agonist Drugs Product
Table Purdue Pharma Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Purdue Pharma Opioids Agonist Drugs Sales Market Share in 2017
Figure Global Purdue Pharma Opioids Agonist Drugs Revenue Market Share in 2017
Table Titan pharmaceuticals Headquarter, Established, Main Business and Finance Overview (2017)
Table Titan pharmaceuticals Opioids Agonist Drugs Production Bases, Sales Regions and Major Competitors
Table Titan pharmaceuticals Opioids Agonist Drugs Product
Table Titan pharmaceuticals Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Titan pharmaceuticals Opioids Agonist Drugs Sales Market Share in 2017
Figure Global Titan pharmaceuticals Opioids Agonist Drugs Revenue Market Share in 2017
Table Boehringer Ingelheim Headquarter, Established, Main Business and Finance Overview (2017)
Table Boehringer Ingelheim Opioids Agonist Drugs Production Bases, Sales Regions and Major Competitors
Table Boehringer Ingelheim Opioids Agonist Drugs Product
Table Boehringer Ingelheim Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Boehringer Ingelheim Opioids Agonist Drugs Sales Market Share in 2017
Figure Global Boehringer Ingelheim Opioids Agonist Drugs Revenue Market Share in 2017
Table Janssen Pharmaceuticals, Inc Headquarter, Established, Main Business and Finance Overview (2017)
Table Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Production Bases, Sales Regions and Major Competitors
Table Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Product
Table Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Sales Market Share in 2017
Figure Global Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Revenue Market Share in 2017
Table Sanofi Headquarter, Established, Main Business and Finance Overview (2017)
Table Sanofi Opioids Agonist Drugs Production Bases, Sales Regions and Major Competitors
Table Sanofi Opioids Agonist Drugs Product
Table Sanofi Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Sanofi Opioids Agonist Drugs Sales Market Share in 2017
Figure Global Sanofi Opioids Agonist Drugs Revenue Market Share in 2017
Table Sun Pharmaceuticals Headquarter, Established, Main Business and Finance Overview (2017)
Table Sun Pharmaceuticals Opioids Agonist Drugs Production Bases, Sales Regions and Major Competitors
Table Sun Pharmaceuticals Opioids Agonist Drugs Product
Table Sun Pharmaceuticals Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Sun Pharmaceuticals Opioids Agonist Drugs Sales Market Share in 2017
Figure Global Sun Pharmaceuticals Opioids Agonist Drugs Revenue Market Share in 2017
Table Mallinckrodt Pharmaceuticals Headquarter, Established, Main Business and Finance Overview (2017)
Table Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Production Bases, Sales Regions and Major Competitors
Table Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Product
Table Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Sales Market Share in 2017
Figure Global Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Revenue Market Share in 2017
Table Egalet Corporation Headquarter, Established, Main Business and Finance Overview (2017)
Table Egalet Corporation Opioids Agonist Drugs Production Bases, Sales Regions and Major Competitors
Table Egalet Corporation Opioids Agonist Drugs Product
Table Egalet Corporation Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Egalet Corporation Opioids Agonist Drugs Sales Market Share in 2017
Figure Global Egalet Corporation Opioids Agonist Drugs Revenue Market Share in 2017
Table Endo Pharmaceuticals Inc. Headquarter, Established, Main Business and Finance Overview (2017)
Table Endo Pharmaceuticals Inc. Opioids Agonist Drugs Production Bases, Sales Regions and Major Competitors
Table Endo Pharmaceuticals Inc. Opioids Agonist Drugs Product
Table Endo Pharmaceuticals Inc. Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Endo Pharmaceuticals Inc. Opioids Agonist Drugs Sales Market Share in 2017
Figure Global Endo Pharmaceuticals Inc. Opioids Agonist Drugs Revenue Market Share in 2017
Table Allergan, Plc Headquarter, Established, Main Business and Finance Overview (2017)
Table Allergan, Plc Opioids Agonist Drugs Production Bases, Sales Regions and Major Competitors
Table Allergan, Plc Opioids Agonist Drugs Product
Table Allergan, Plc Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Allergan, Plc Opioids Agonist Drugs Sales Market Share in 2017
Figure Global Allergan, Plc Opioids Agonist Drugs Revenue Market Share in 2017
Table Pfizer Inc
Table Pfizer Inc Opioids Agonist Drugs
Table Global Opioids Agonist Drugs Sales by Manufacturer (2016-2017)
Figure Global Opioids Agonist Drugs Sales Market Share by Manufacturer in 2016
Figure Global Opioids Agonist Drugs Sales Market Share by Manufacturer in 2017
Table Global Opioids Agonist Drugs Revenue by Manufacturer (2016-2017)
Figure Global Opioids Agonist Drugs Revenue Market Share by Manufacturer in 2016
Figure Global Opioids Agonist Drugs Revenue Market Share by Manufacturer in 2017
Table Global Opioids Agonist Drugs Price by Manufacturer (2016-2017)
Figure Top 3 Opioids Agonist Drugs Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Opioids Agonist Drugs Manufacturer (Revenue) Market Share in 2017
Figure Global Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
Figure Global Opioids Agonist Drugs Revenue and Growth Rate (2013-2018)
Table Global Opioids Agonist Drugs Sales by Regions (2013-2018)
Table Global Opioids Agonist Drugs Sales Market Share by Regions (2013-2018)
Table Global Opioids Agonist Drugs Revenue by Regions (2013-2018)
Figure Global Opioids Agonist Drugs Revenue Market Share by Regions in 2013
Figure Global Opioids Agonist Drugs Revenue Market Share by Regions in 2017
Figure North America Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
Figure North America Opioids Agonist Drugs Revenue and Growth Rate (2013-2018)
Figure Europe Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
Figure Europe Opioids Agonist Drugs Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Opioids Agonist Drugs Revenue and Growth Rate (2013-2018)
Figure South America Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
Figure South America Opioids Agonist Drugs Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Opioids Agonist Drugs Revenue and Growth Rate (2013-2018)
Figure North America Opioids Agonist Drugs Revenue and Growth Rate (2013-2018)
Table North America Opioids Agonist Drugs Sales by Countries (2013-2018)
Table North America Opioids Agonist Drugs Sales Market Share by Countries (2013-2018)
Figure North America Opioids Agonist Drugs Sales Market Share by Countries in 2013
Figure North America Opioids Agonist Drugs Sales Market Share by Countries in 2017
Table North America Opioids Agonist Drugs Revenue by Countries (2013-2018)
Table North America Opioids Agonist Drugs Revenue Market Share by Countries (2013-2018)
Figure North America Opioids Agonist Drugs Revenue Market Share by Countries in 2013
Figure North America Opioids Agonist Drugs Revenue Market Share by Countries in 2017
Figure United States Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
Figure Canada Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
Figure Mexico Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
Table North America Opioids Agonist Drugs Sales by Manufacturer (2016-2017)
Figure North America Opioids Agonist Drugs Sales Market Share by Manufacturer in 2016
Figure North America Opioids Agonist Drugs Sales Market Share by Manufacturer in 2017
Table North America Opioids Agonist Drugs Revenue by Manufacturer (2016-2017)
Figure North America Opioids Agonist Drugs Revenue Market Share by Manufacturer in 2016
Figure North America Opioids Agonist Drugs Revenue Market Share by Manufacturer in 2017
Table North America Opioids Agonist Drugs Sales by Type (2013-2018)
Table North America Opioids Agonist Drugs Sales Share by Type (2013-2018)
Table North America Opioids Agonist Drugs Revenue by Type (2013-2018)
Table North America Opioids Agonist Drugs Revenue Share by Type (2013-2018)
Table North America Opioids Agonist Drugs Sales by Application (2013-2018)
Table North America Opioids Agonist Drugs Sales Share by Application (2013-2018)
Table North America Opioids Agonist Drugs Revenue by Application (2013-2018)
Table North America Opioids Agonist Drugs Revenue Share by Application (2013-2018)
Figure Europe Opioids Agonist Drugs Revenue and Growth Rate (2013-2018)
Table Europe Opioids Agonist Drugs Sales by Countries (2013-2018)
Table Europe Opioids Agonist Drugs Sales Market Share by Countries (2013-2018)
Table Europe Opioids Agonist Drugs Revenue by Countries (2013-2018)
Figure Europe Opioids Agonist Drugs Revenue Market Share by Countries in 2016
Figure Europe Opioids Agonist Drugs Revenue Market Share by Countries in 2017
Figure Germany Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
Figure UK Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
Figure France Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
Figure Russia Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
Figure Italy Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
Table Europe Opioids Agonist Drugs Sales by Manufacturer (2016-2017)
Figure Europe Opioids Agonist Drugs Sales Market Share by Manufacturer in 2016
Figure Europe Opioids Agonist Drugs Sales Market Share by Manufacturer in 2017
Table Europe Opioids Agonist Drugs Revenue by Manufacturer (2016-2017)
Figure Europe Opioids Agonist Drugs Revenue Market Share by Manufacturer in 2016
Figure Europe Opioids Agonist Drugs Revenue Market Share by Manufacturer in 2017
Table Europe Opioids Agonist Drugs Sales by Type (2013-2018)
Table Europe Opioids Agonist Drugs Sales Share by Type (2013-2018)
Table Europe Opioids Agonist Drugs Revenue by Type (2013-2018)
Table Europe Opioids Agonist Drugs Revenue Share by Type (2013-2018)
Table Europe Opioids Agonist Drugs Sales by Application (2013-2018)
Table Europe Opioids Agonist Drugs Sales Share by Application (2013-2018)
Table Europe Opioids Agonist Drugs Revenue by Application (2013-2018)
Table Europe Opioids Agonist Drugs Revenue Share by Application (2013-2018)
Figure Asia-Pacific Opioids Agonist Drugs Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Opioids Agonist Drugs Sales by Countries (2013-2018)
Table Asia-Pacific Opioids Agonist Drugs Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Opioids Agonist Drugs Sales Market Share by Countries 2017
Table Asia-Pacific Opioids Agonist Drugs Revenue by Countries (2013-2018)
Figure Asia-Pacific Opioids Agonist Drugs Revenue Market Share by Countries 2017
Figure China Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
Figure Japan Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
Figure Korea Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
Figure India Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
Figure Southeast Asia Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
Table Asia-Pacific Opioids Agonist Drugs Sales by Manufacturer (2016-2017)
Figure Asia-Pacific Opioids Agonist Drugs Sales Market Share by Manufacturer in 2016
Figure Asia-Pacific Opioids Agonist Drugs Sales Market Share by Manufacturer in 2017
Table Asia-Pacific Opioids Agonist Drugs Revenue by Manufacturer (2016-2017)
Figure Asia-Pacific Opioids Agonist Drugs Revenue Market Share by Manufacturer in 2016
Figure Asia-Pacific Opioids Agonist Drugs Revenue Market Share by Manufacturer in 2017
Table Asia-Pacific Opioids Agonist Drugs Sales by Type (2013-2018)
Table Asia-Pacific Opioids Agonist Drugs Sales Share by Type (2013-2018)
Table Asia-Pacific Opioids Agonist Drugs Revenue by Type (2013-2018)
Table Asia-Pacific Opioids Agonist Drugs Revenue Share by Type (2013-2018)
Table Asia-Pacific Opioids Agonist Drugs Sales by Application (2013-2018)
Table Asia-Pacific Opioids Agonist Drugs Sales Share by Application (2013-2018)
Table Asia-Pacific Opioids Agonist Drugs Revenue by Application (2013-2018)
Table Asia-Pacific Opioids Agonist Drugs Revenue Share by Application (2013-2018)
Figure South America Opioids Agonist Drugs Revenue and Growth Rate (2013-2018)
Table South America Opioids Agonist Drugs Sales by Countries (2013-2018)
Table South America Opioids Agonist Drugs Sales Market Share by Countries (2013-2018)
Figure South America Opioids Agonist Drugs Sales Market Share by Countries in 2017
Table South America Opioids Agonist Drugs Revenue by Countries (2013-2018)
Table South America Opioids Agonist Drugs Revenue Market Share by Countries (2013-2018)
Figure South America Opioids Agonist Drugs Revenue Market Share by Countries in 2017
Figure Brazil Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
Figure Argentina Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
Figure Colombia Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
Table South America Opioids Agonist Drugs Sales by Manufacturer (2016-2017)
Figure South America Opioids Agonist Drugs Sales Market Share by Manufacturer in 2016
Figure South America Opioids Agonist Drugs Sales Market Share by Manufacturer in 2017
Table South America Opioids Agonist Drugs Revenue by Manufacturer (2016-2017)
Figure South America Opioids Agonist Drugs Revenue Market Share by Manufacturer in 2016
Figure South America Opioids Agonist Drugs Revenue Market Share by Manufacturer in 2017
Table South America Opioids Agonist Drugs Sales by Type (2013-2018)
Table South America Opioids Agonist Drugs Sales Share by Type (2013-2018)
Table South America Opioids Agonist Drugs Revenue by Type (2013-2018)
Table South America Opioids Agonist Drugs Revenue Share by Type (2013-2018)
Table South America Opioids Agonist Drugs Sales by Application (2013-2018)
Table South America Opioids Agonist Drugs Sales Share by Application (2013-2018)
Table South America Opioids Agonist Drugs Revenue by Application (2013-2018)
Table South America Opioids Agonist Drugs Revenue Share by Application (2013-2018)
Figure Middle East and Africa Opioids Agonist Drugs Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Opioids Agonist Drugs Sales by Countries (2013-2018)
Table Middle East and Africa Opioids Agonist Drugs Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Opioids Agonist Drugs Sales Market Share by Countries in 2017
Table Middle East and Africa Opioids Agonist Drugs Revenue by Countries (2013-2018)
Table Middle East and Africa Opioids Agonist Drugs Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Opioids Agonist Drugs Revenue Market Share by Countries in 2013
Figure Middle East and Africa Opioids Agonist Drugs Revenue Market Share by Countries in 2017
Figure Saudi Arabia Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
Figure UAE Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
Figure Egypt Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
Figure Nigeria Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
Figure South Africa Opioids Agonist Drugs Sales and Growth Rate (2013-2018)
Table Middle East and Africa Opioids Agonist Drugs Sales by Manufacturer (2016-2017)
Figure Middle East and Africa Opioids Agonist Drugs Sales Market Share by Manufacturer in 2016
Figure Middle East and Africa Opioids Agonist Drugs Sales Market Share by Manufacturer in 2017
Table Middle East and Africa Opioids Agonist Drugs Revenue by Manufacturer (2016-2017)
Figure Middle East and Africa Opioids Agonist Drugs Revenue Market Share by Manufacturer in 2016
Figure Middle East and Africa Opioids Agonist Drugs Revenue Market Share by Manufacturer in 2017
Table Middle East and Africa Opioids Agonist Drugs Sales by Type (2013-2018)
Table Middle East and Africa Opioids Agonist Drugs Sales Share by Type (2013-2018)
Table Middle East and Africa Opioids Agonist Drugs Revenue by Type (2013-2018)
Table Middle East and Africa Opioids Agonist Drugs Revenue Share by Type (2013-2018)
Table Middle East and Africa Opioids Agonist Drugs Sales by Application (2013-2018)
Table Middle East and Africa Opioids Agonist Drugs Sales Share by Application (2013-2018)
Table Middle East and Africa Opioids Agonist Drugs Revenue by Application (2013-2018)
Table Middle East and Africa Opioids Agonist Drugs Revenue Share by Application (2013-2018)
Table Global Opioids Agonist Drugs Sales by Type (2013-2018)
Table Global Opioids Agonist Drugs Sales Share by Type (2013-2018)
Table Global Opioids Agonist Drugs Revenue by Type (2013-2018)
Table Global Opioids Agonist Drugs Revenue Share by Type (2013-2018)
Figure Global Codeine Sales Growth (2013-2018)
Figure Global Codeine Price (2013-2018)
Figure Global Fentanyl Sales Growth (2013-2018)
Figure Global Fentanyl Price (2013-2018)
Figure Global Meperidine Sales Growth (2013-2018)
Figure Global Meperidine Price (2013-2018)
Figure Global Methadone Sales Growth (2013-2018)
Figure Global Methadone Price (2013-2018)
Figure Global Morphine Sales Growth (2013-2018)
Figure Global Morphine Price (2013-2018)
Figure Global Hydrocodone Sales Growth (2013-2018)
Figure Global Hydrocodone Price (2013-2018)
Table Global Opioids Agonist Drugs Sales by Application (2013-2018)
Table Global Opioids Agonist Drugs Sales Share by Application (2013-2018)
Figure Global Pain Management Sales Growth (2013-2018)
Figure Global Cough Treatment Sales Growth (2013-2018)
Figure Global Diarrhea Treatment Sales Growth (2013-2018)
Figure Global Opioids Agonist Drugs Sales, Revenue and Growth Rate (2018-2023)
Table Global Opioids Agonist Drugs Sales Forecast by Regions (2018-2023)
Table Global Opioids Agonist Drugs Market Share Forecast by Regions (2018-2023)
Figure North America Sales Opioids Agonist Drugs Market Forecast (2018-2023)
Figure Europe Sales Opioids Agonist Drugs Market Forecast (2018-2023)
Figure Asia-Pacific Sales Opioids Agonist Drugs Market Forecast (2018-2023)
Figure South America Sales Opioids Agonist Drugs Market Forecast (2018-2023)
Figure Middle East and Africa Sales Opioids Agonist Drugs Market Forecast (2018-2023)
Table Global Opioids Agonist Drugs Sales Forecast by Type (2018-2023)
Table Global Opioids Agonist Drugs Market Share Forecast by Type (2018-2023)
Table Global Opioids Agonist Drugs Sales Forecast by Application (2018-2023)
Table Global Opioids Agonist Drugs Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List